Cathie Wood’s ARK Invest Buys Over 400,000 Shares of CRISPR
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 400,000 shares of CRISPR Therapeutics on October 10.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Friday. Specifically, these exchange-traded funds bought roughly $40 million worth of CRISPR Therapeutics AG (NASDAQ: CRSP | CRSP Price Prediction), as the prices of these funds were very mixed on Friday. Note that they are up only slightly in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 136,060 shares of CRISPR, and ARK Innovation ETF (NYSEARCA: ARKK) bought 268,472 shares. At Friday’s closing prices, this would have valued the sales at roughly $39.9 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The innovation ETF is up about 12% and the other is up 1% in the past year.
Check out all the ARK Invest purchases for Friday as well:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | DNA | GINKGO BIOWORKS | 1,535,517 |
| ARKG | ACCD | ACCOLADE | 347,467 |
| ARKG | CRSP | CRISPR THERAPEUTICS | 136,060 |
| ARKG | NTLA | INTELLIA THERAPEUTICS | 106,395 |
| ARKG | BEAM | BEAM THERAPEUTICS | 37,753 |
| ARKG | TDOC | TELADOC HEALTH | 12,496 |
| ARKG | QSI | QUANTUM-SI | 112,210 |
| ARKG | SURF | SURFACE ONCOLOGY | 75,405 |
| ARKG | SLGC | SOMALOGIC | 21,202 |
| ARKG | DYNS | DYNAMICS SPECIAL PURPOSE | 1,005 |
| ARKK | NTLA | INTELLIA THERAPEUTICS | 269,179 |
| ARKK | CRSP | CRISPR THERAPEUTICS | 268,472 |
| ARKK | BEAM | BEAM THERAPEUTICS | 129,130 |
| ARKK | TDOC | TELADOC HEALTH | 81,569 |
| ARKK | SGFY | SIGNIFY HEALTH | 290,491 |
| ARKK | TWOU | 2U | 49,563 |
| ARKK | SSYS | STRATASYS | 616 |
| ARKQ | ACHR | ARCHER AVIATION | 294,655 |
| ARKQ | NIU | NIU TECHNOLOGIES | 40,310 |
| ARKQ | MKFG | MARKFORGED | 129,096 |
| ARKQ | VLD | VELO3D | 17,021 |
| ARKX | ACHR | ARCHER AVIATION | 37,823 |
| ARKX | PRNT | 3D PRINTING ETF | 5,678 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
[recirclink id=970204][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.
